Neuropathy

Medicinal Cannabis: Trigeminal Neuralgy

TRIGEMINAL NEURALGy IS A PATHOLOGY THAT GENERATES INTENSE PAIN AND IS UNLEASHED BY MINIMUM STIMULES. SOME PEOPLE GET REMARKABLE IMPROVEMENT WITH CANNABIS.

Trigeminal neuralgy is a neuropathic syndrome that produces very intense pain crises in the lips, gums, chin, nose, eyes, ears and the entire area of the trigeminal nerve, the irritation  which explains the syndrome.

The attacks are generally unilateral, start abruptly, and last from minutes to hours.

The pain is usually sharp, stabbing and burning.

Traditional treatment

The drug of first choice is carbamazepine, since it resolves between 50 and 75% of cases. If the condition does not respond well to this drug, usually will be used other antiepileptic drugs  such as oxcarbazepine, lamotrigine, or phenytoin.

Also are indicated opioids, antidepressants, and pregabalin  Many patients become resistant or cannot tolerate the side effects of the medications.

In some cases there is a surgical option necessary, such as microvascular decompression or radio surgery.

Cannabis treatment

The answer is very varied: there are people who have no effect when using cannabis oil, while others improve considerably from the incorporation of Full Spectrum CBD.

The response to the inhaled route is also variable: while some suffer aggravation of seizures when vaporizing marijuana, others are life-changing. Those who present a good response to this therapy report improvement in pain, sleep and mood.

In many cases it makes possible to suspend drug therapy, which improves quality of life, since the drugs indicated usually bring unwanted side effects (for example, carbamazepine produces menstrual alterations in 45% of women).

IN MANY CASES, THE USE OF CANNABIS CAN SUSPEND PHARMACOTHERAPY, WHICH IMPROVES QUALITY OF LIFE, SINCE THE INDICATED DRUGS USUALLY BRING UNWANTED SIDE EFFECTS.

 

Yana Djonua

Recent Posts

CBD Cuts Seizures by 38.6% in a Multicenter Genetic Epilepsy Study

CBD Cuts Seizures by 38.6% in a Multicenter Genetic Epilepsy Study The landscape of epilepsy…

1 week ago

CBD Cuts Seizures by 38.6% in a Multicenter Genetic Epilepsy Study

CBD Cuts Seizures by 38.6% in a Multicenter Genetic Epilepsy Study In recent years, cannabidiol…

2 weeks ago

Synthetic Cannabinoids Trigger Distinct Inflammatory Shifts in Brain Regions

Synthetic Cannabinoids Trigger Distinct Inflammatory Shifts in Brain Regions Synthetic cannabinoids have been thrust into…

2 weeks ago

Cannabis in Sports: Decoding THC and CBD’s Impact on Recovery

Cannabis in Sports: Decoding THC and CBD's Impact on Recovery As athletes continuously search for…

1 month ago

Medical Cannabis Yields Nearly 50% IBD Remission, Study Finds

Medical Cannabis Yields Nearly 50% IBD Remission, Study Finds Medical cannabis continues to generate discussion…

1 month ago

Chronic Cannabis Use and Metabolic Changes: Are Diabetes Risks Elevated?

Introduction As cannabis becomes increasingly prevalent in public discourse, understanding its broader health impacts is…

1 month ago